Isolation and identification of SARS-CoV-2 antibodies from COVID-19 patient samples
<p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causing agent for COVID-19, has led to over 7 million deaths since it was first detected in Wuhan, China in December 2019. Antibodies induced by both vaccination and infection are crucial for the immune protection ag...
Hlavní autor: | Liu, C |
---|---|
Další autoři: | Screaton, GR |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
2024
|
Témata: |
Podobné jednotky
-
SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tract
Autor: Alba Escalera, a další
Vydáno: (2024-03-01) -
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection
Autor: Xiao-Lin Jiang, a další
Vydáno: (2024-07-01) -
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2
Autor: Cyril Planchais, a další
Vydáno: (2024-07-01) -
SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness
Autor: Jeewandara, C, a další
Vydáno: (2021) -
Cross-reactive immunity to SARS-CoV-2 and related coronaviruses
Autor: Jay, C
Vydáno: (2023)